ATLASOruka Therapeutics (ORKA) earnings date: Nov 11, 2026
Oruka Therapeutics (ORKA) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026, before the open. Analysts expect EPS of -$0.68.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ORKA
| Last price | $96.87 (+0.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.6% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Oruka Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Oruka Therapeutics reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Oruka Therapeutics. You can switch it off at any time.
Alert me before ORKA reportsFree to start. Creating an account takes under a minute.
ORKA earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.68 |
| Last report | Aug 10, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +3.6% |
| Average move around a report | ±6.8% (last 5) |
| Sector | Healthcare · Biotechnology |
Oruka Therapeutics earnings history: last 5 reports
Oruka Therapeutics last reported on Aug 10, 2026: EPS of -$0.55 against an estimate of -$0.50 (-10.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | -$0.50 | -$0.55 | -10.0% | Miss | +5.9% |
| May 13, 2026 | -$0.54 | -$0.48 | +11.1% | Beat | -1.2% |
| Mar 12, 2026 | -$0.62 | -$0.45 | +27.4% | Beat | +16.3% |
| Nov 12, 2025 | -$0.52 | -$0.55 | -5.8% | Miss | -6.5% |
| Nov 4, 2025 | $3.16 | $3.01 | -4.7% | Miss | +4.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ORKA
See the fair value, the probability range and the earnings history of Oruka Therapeutics on its ATLAS page.
Oruka Therapeutics (ORKA) stock analysisPlans from €3.99 a month.
Oruka Therapeutics earnings: frequently asked questions
When does Oruka Therapeutics (ORKA) report earnings?
Oruka Therapeutics is scheduled to report on Wednesday, November 11, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ORKA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.68 per share (USD). Estimates can change before the report.
How often does ORKA beat earnings estimates?
Of its last 5 reports with a recorded result, Oruka Therapeutics beat the EPS estimate 2 times; the average surprise was +3.6%. Past results do not predict the next one.
How much does ORKA move around earnings?
Over its last 5 reports the stock moved an average of 6.8% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Oruka Therapeutics beat earnings estimates last quarter?
Oruka Therapeutics last reported on Aug 10, 2026: EPS of -$0.55 against an estimate of -$0.50 (-10.0% surprise), a miss.
How much does ORKA usually move in a day?
On a normal trading day the ATLAS model puts ORKA’s one-day range at about ±3.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer